Managers / Q4 2020 · view latest →
One68 Global Capital, LLC
CIK 0001755535 · 135 WEST 50TH STREET, SUITE 200, NEW YORK, NY, 10020 · 212-331-6783
Reported Value
$50M
Q4 2020
Positions
119
Filings on Record
20
2019–present window
Filed
Feb 16, 2021
original filing
Summary
One68 Global Capital, LLC reported $50M in U.S.-listed holdings across 119 positions for Q4 2020.
Its largest position, National Gen, represents 9.0% of the portfolio.
Compared with Q3 2020, the fund opened 101 new positions and exited 20.
Portfolio Metrics
Turnover
+61.2%
vs prior filed quarter
Top-10 Concentration
+44.9%
share of reported value
Largest Position
+9.0%
National Gen
New / Exited
101 / 20
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 64.0% · $32M
- Other · 32.1% · $16M
- ADR · 2.3% · $1M
- Unit · 0.9% · $471,000
- REIT · 0.4% · $194,000
- Right · 0.3% · $136,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NATIONAL GEN HLDGS CORP | NEW | +131.0K | 131.0K | +$4M | $4M |
| WORKSLACK TECHNOLOGIES INC | NEW | +96.0K | 96.0K | +$4M | $4M |
| IHS MARKIT LTD | NEW | +20.0K | 20.0K | +$2M | $2M |
| ALXNALEXION PHARMACEUTICALS INC | NEW | +10.0K | 10.0K | +$2M | $2M |
| DDDUPONT DE NEMOURS INC | NEW | +20.0K | 20.0K | +$1M | $1M |
| ADIANALOG DEVICES INC | NEW | +8.2K | 8.2K | +$1M | $1M |
| BMYBRISTOL-MYERS SQUIBB CO | NEW | +17.0K | 17.0K | +$1M | $1M |
| CAHCARDINAL HEALTH INC | NEW | +15.0K | 15.0K | +$803,000 | $803,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
118 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NATIONAL GEN HLDGS CORP | Common Stock | 8.99% | $4M | 131.0K |
| 2 | WORKSLACK TECHNOLOGIES INChistory → | Common Stock | 8.14% | $4M | 96.0K |
| 3 | ACIAACACIA COMMUNICATIONS INChistory → | Common Stock | 5.78% | $3M | 39.5K |
| 4 | VIRTUSA CORP | Common Stock | 4.73% | $2M | 46.1K |
| 5 | IHS MARKIT LTD | Common Stock | 3.61% | $2M | 20.0K |
| 6 | ALXNALEXION PHARMACEUTICALS INChistory → | Common Stock | 3.15% | $2M | 10.0K |
| 7 | DDDUPONT DE NEMOURS INChistory → | Common Stock | 2.85% | $1M | 20.0K |
| 8 | GRWGGROWGENERATION CORPhistory → | Common Stock | 2.84% | $1M | 35.1K |
| 9 | ADIANALOG DEVICES INChistory → | Common Stock | 2.43% | $1M | 8.2K |
| 10 | BMYBRISTOL-MYERS SQUIBB CO | Common Stock · Right 99/99/9999 | 2.39% | $1M | 214.6K |
| 11 | LIONHEART ACQUISITION CORP I | Unit | 2.03% | $1M | 97.3K |
| 12 | TAT&T INChistory → | Common Stock | 2.02% | $1M | 35.0K |
| 13 | PFEPFIZER INChistory → | Common Stock | 1.85% | $920,000 | 25.0K |
| 14 | CAHCARDINAL HEALTH INChistory → | Common Stock | 1.61% | $803,000 | 15.0K |
| 15 | INTCINTEL CORPhistory → | Common Stock | 1.56% | $775,000 | 15.7K |
| 16 | MARVELL TECHNOLOGY GROUP LTD | Common Stock | 1.43% | $713,000 | 15.0K |
| 17 | VARIAN MED SYS INC | Common Stock | 1.41% | $705,000 | 4.0K |
| 18 | COLLECTORS UNIVERSE INC | Common Stock | 1.23% | $615,000 | 8.2K |
| 19 | RPREALPAGE INChistory → | Common Stock | 1.23% | $611,000 | 7.0K |
| 20 | NVONOVO-NORDISK A Shistory → | ADR | 1.18% | $588,000 | 8.4K |
| 21 | PROSHARES TR II | ETP | 1.15% | $575,000 | 54.0K |
| 22 | 51JOB INC | ADR | 1.15% | $574,000 | 8.2K |
| 23 | MRNAMODERNA INChistory → | Common Stock | 1.05% | $522,000 | 5.0K |
| 24 | GX ACQUISITION CORP | Common Stock | 1.04% | $520,000 | 47.3K |
| 25 | MALACCA STRAITS ACQUISITION | Unit 99/99/9999 | 1.03% | $514,000 | 50.0K |
| 26 | AMDADVANCED MICRO DEVICES INC | Common Stock | 0.96% | $477,000 | 5.2K |
| 27 | CHURCHILL CAPITAL CORP IV | Unit | 0.95% | $471,000 | 45.7K |
| 28 | REDBALL ACQUISITION CORP | Unit 99/99/9999 | 0.94% | $470,000 | 40.7K |
| 29 | GDRXGOODRX HLDINGS INC | Common Stock | 0.87% | $432,000 | 10.7K |
| 30 | GILDGILEAD SCIENCES INC | Common Stock | 0.82% | $408,000 | 7.0K |
| 31 | ACE CONVERGENCE ACQU CORP | UNIT 99/99/9999 | 0.77% | $386,000 | 35.4K |
| 32 | GIGCAPITAL2 INC | Common Stock | 0.73% | $363,000 | 33.2K |
| 33 | VTRSVIATRIS INC | Common Stock | 0.66% | $331,000 | 17.6K |
| 34 | CHPMCHP MERGER CORP | Common Stock | 0.64% | $318,000 | 31.0K |
| 35 | FTAC OLYMPUS ACQUISITION COR | Common Stock | 0.62% | $308,000 | 29.9K |
| 36 | ELANELANCO ANIMAL HEALTH INC | Common Stock | 0.62% | $307,000 | 10.0K |
| 37 | KANSAS CITY SOUTHERN | Common Stock | 0.61% | $306,000 | 1.5K |
| 38 | MULTIPLAN CORPORATION | Common Stock | 0.58% | $290,000 | 36.3K |
| 39 | CLGXCORELOGIC INC | Common Stock | 0.55% | $274,000 | 3.5K |
| 40 | CAPSTAR SPL PURP ACQUISITION | Common Stock | 0.55% | $274,000 | 27.0K |
| 41 | KISMET ACQUISITION ONE CORP | UNIT 08/06/2025 | 0.55% | $273,000 | 26.0K |
| 42 | BHCBAUSCH HEALTH COS INC | Common Stock | 0.54% | $270,000 | 13.0K |
| 43 | PRSPPERSPECTA INC | Common Stock | 0.54% | $267,000 | 11.1K |
| 44 | ZANITE ACQUISITION CORP | Unit | 0.53% | $263,000 | 25.0K |
| 45 | GNWGENWORTH FINL INC | Common Stock | 0.50% | $248,000 | 65.7K |
| 46 | BIOTELEMETRY INC | Common Stock | 0.49% | $246,000 | 3.4K |
| 47 | NAM TAI PPTY INC | Common Stock | 0.49% | $244,000 | 41.7K |
| 48 | RIOTRIOT BLOCKCHAIN INC | Common Stock | 0.46% | $227,000 | 13.3K |
| 49 | EXPERIENCE INVT CORP | Common Stock | 0.45% | $222,000 | 20.0K |
| 50 | BEEMBEAM GLOBAL | Common Stock | 0.44% | $221,000 | 3.0K |
| 51 | LUMOS PHARMA INC | Common Stock | 0.42% | $209,000 | 5.9K |
| 52 | ARTIUS ACQUISITION INC | Unit | 0.42% | $207,000 | 18.4K |
| 53 | VROOM INC | Common Stock | 0.41% | $205,000 | 5.0K |
| 54 | GREENROSE ACQUISITION CORP | Common Stock | 0.41% | $203,000 | 20.0K |
| 55 | FRONT YD RESIDENTIAL CORP | REIT | 0.39% | $194,000 | 12.0K |
| 56 | MOHAWK GROUP HLDGS INC | Common Stock | 0.37% | $186,000 | 10.8K |
| 57 | CC NEUBERGER PRINCIPAL HLDNG | Common Stock | 0.37% | $183,000 | 16.9K |
| 58 | INFRA AND ENERGY ALTRNTIVE I | Common Stock | 0.35% | $172,000 | 10.4K |
| 59 | CLPTCLEARPOINT NEURO INC | Common Stock | 0.33% | $166,000 | 10.4K |
| 60 | AMERICAN VRTUAL CLOUD TECH I | Common Stock | 0.32% | $157,000 | 21.8K |
| 61 | ACRSACLARIS THERAPEUTICS INC | Common Stock | 0.32% | $157,000 | 24.3K |
| 62 | STARBOARD VALUE ACQUISITN CO | UNIT 09/10/2025 | 0.31% | $155,000 | 15.0K |
| 63 | NIKOLA CORP | Common Stock | 0.31% | $153,000 | 10.0K |
| 64 | HIGHCAPE CAP ACQUISITION COR | Common Stock | 0.31% | $152,000 | 15.0K |
| 65 | BARNES & NOBLE ED INC | Common Stock | 0.30% | $151,000 | 32.4K |
| 66 | TWITITAN INTL INC ILL | Common Stock | 0.30% | $150,000 | 30.8K |
| 67 | ONCTERNAL THERAPEUTICS INC | Common Stock | 0.30% | $150,000 | 30.7K |
| 68 | REKRREKOR SYSTEMS INC | Common Stock | 0.30% | $148,000 | 18.3K |
| 69 | VUZIVUZIX CORP | Common Stock | 0.30% | $148,000 | 16.3K |
| 70 | VISION MARINE TECHNOLOGIES I | Common Stock | 0.30% | $148,000 | 11.0K |
| 71 | TUSKMAMMOTH ENERGY SVCS INC | Common Stock | 0.29% | $147,000 | 33.1K |
| 72 | MARATHON PATENT GROUP INC | Common Stock | 0.29% | $146,000 | 14.0K |
| 73 | LIVEXLIVE MEDIA INC | Common Stock | 0.29% | $145,000 | 44.1K |
| 74 | ONCOSEC MED INC | Common Stock | 0.29% | $144,000 | 22.3K |
| 75 | AQUABOUNTY TECHNOLOGIES INC | Common Stock | 0.29% | $143,000 | 16.4K |
| 76 | STIMNEURONETICS INC | Common Stock | 0.28% | $142,000 | 12.8K |
| 77 | OTONOMY INC | Common Stock | 0.28% | $140,000 | 21.6K |
| 78 | CMLSQCUMULUS MEDIA INC | Common Stock | 0.28% | $140,000 | 16.0K |
| 79 | SURFACE ONCOLOGY INC | Common Stock | 0.28% | $139,000 | 15.1K |
| 80 | FITBIT INC | Common Stock | 0.27% | $136,000 | 20.0K |
| 81 | CVGICOMMERCIAL VEH GROUP INC | Common Stock | 0.27% | $135,000 | 15.6K |
| 82 | FG NEW AMER ACQUISITION CORP | Common Stock | 0.27% | $134,000 | 13.2K |
| 83 | SICSELECT INTERIOR CONCEPTS INC | Common Stock | 0.27% | $133,000 | 18.6K |
| 84 | FUVARCIMOTO INC | Common Stock | 0.27% | $133,000 | 10.0K |
| 85 | PMV CONSUMER ACQUISITION COR | Common Stock | 0.26% | $132,000 | 13.0K |
| 86 | TAILWIND ACQUISITION CORP | Common Stock | 0.26% | $132,000 | 12.7K |
| 87 | HORIZON GLOBAL CORP | Common Stock | 0.26% | $130,000 | 15.2K |
| 88 | Tuscan HLDGS CORP II | Common Stock | 0.26% | $129,000 | 11.7K |
| 89 | REMARK HLDNG INC | Common Stock | 0.25% | $127,000 | 66.6K |
| 90 | YRC WORLDWIDE INC | Common Stock | 0.25% | $126,000 | 28.5K |
| 91 | BWBABCOCK & WILCOX ENTERPRISES | Common Stock | 0.25% | $126,000 | 35.8K |
| 92 | CTI BIOPHARMA CORP | Common Stock | 0.25% | $126,000 | 39.1K |
| 93 | LINCLINCOLN EDL SVCS CORP | Common Stock | 0.25% | $125,000 | 19.2K |
| 94 | ALDXALDEYRA THERAPEUTICS INC | Common Stock | 0.25% | $123,000 | 17.9K |
| 95 | ALTALTIMMUNE INC | Common Stock | 0.24% | $122,000 | 10.8K |
| 96 | YUCAIPA ACQUISITION CORP | Common Stock | 0.24% | $118,000 | 11.7K |
| 97 | ABUSARBUTUS BIOPHARMA CORP | Common Stock | 0.23% | $113,000 | 31.9K |
| 98 | PETROS PHARMACEUTICALS INC | Common Stock | 0.22% | $109,000 | 24.9K |
| 99 | HUDSON EXECUTIVE INVT CORP | Common Stock | 0.22% | $108,000 | 10.0K |
| 100 | WTWISDOMTREE INVTS INC | Common Stock | 0.21% | $107,000 | 20.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $31M | 40 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $8M | 35 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $6M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $0 | 1 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $204M | 90 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $188M | 98 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $16M | 28 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $70M | 57 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $36M | 25 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $38M | 39 | May 18, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $50M | 119 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $38M | 39 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $27M | 21 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $10M | 10 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $46M | 78 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $44M | 14 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $79M | 18 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $33M | 18 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $22M | 12 | Feb 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.